Latest ATXI reports update at 2024-05-15: 2024-Q1 ∙ 2023-Q4 ∙ 2023-Q1

Avenue Therapeutics ATXI

$ 4.15 -5.68%

Avenue Therapeutics Financial Statements 2011-2024 | ATXI

Annual Financial Statements Avenue Therapeutics

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	1.69 M	2.29 M	385 K	97.8 M	149 M	63.7 M	25.7 M	-	-	-	-	-	-
Shares	10.6 M	2.19 M	1.13 M	16.5 M	15.7 M	10.2 M	6.63 M	-	-	-	-	-	-
Historical Prices	0.16	1.05	0.34	4.7	8.88	5.55	5.11	-	-	-	-	-	-
Net Income	-10.5 M	-3.6 M	-3.73 M	-5.15 K	-25.9 M	-21.5 M	-12.3 M	-3.18 M	-5.23 M	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-14.5 M	-8.04 M	-3.74 M	-5.21 M	-26.3 M	-21.8 M	-11.4 M	-2.38 M	-4.84 M	-	-	-	-
Interest Expense	-	-	-	-	-	-	294 K	420 K	215 K	-	-	-	-
EBITDA	-14.5 M	-8.04 M	-3.74 M	-5.21 K	-26.3 M	-21.5 M	-11.4 M	-2.38 M	-5.61 M	-	-	-	-
Operating Expenses	-	-	-	5.21 K	26.3 M	21.8 M	11.4 M	2.38 M	4.84 M	-	-	-	-
General and Administrative Expenses	4.18 M	5.34 M	2.48 M	2.35 K	3.07 M	4.12 M	3.62 M	997 K	882 K	-	-	-	-

All numbers in USD currency

Quarterly Income Statement Avenue Therapeutics

	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	562 K	341 K	8.11 M	7.92 M	74.2 K	4.77 M	1.47 M	21.9 M	1.4 M	1.41 M	1.11 M	16.6 M	16.6 M	16.7 M	16.5 M	16.5 M	16.5 M	16.7 M	16.4 M	16.3 M	13.7 M	10.7 M	10.3 M	10.3 M	10.1 M	10.3 M	9.97 M	3.46 M	3.02 M	3.26 M	2.85 M	2.79 M	8.31 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-4.35 M	-	513 K	-4.02 M	-7.6 M	-	-662 K	-604 K	-2.86 M	-	-871 K	-949 K	-998 K	-	-1.03 M	-1.89 M	-1.24 M	-	-2.24 M	-6.98 M	-11.3 M	-	-2.6 M	-4.66 M	-10.4 M	-6.24 M	-2.95 M	-2.41 M	-661 K	-815 K	-544 K	-771 K	-1.05 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-3.71 M	-	-2.07 M	-3.92 M	-6.43 M	-	-663 K	-605 K	-2.86 M	-	-872 K	-951 K	-1 M	-	-1.04 M	-1.9 M	-1.27 M	-	-2.32 M	-7.11 M	-11.4 M	-	-2.61 M	-4.68 M	-10.4 M	-	-2.85 M	-1.74 M	-504 K	-	-383 K	-638 K	-840 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	82 K	106 K	93 K	95 K	-299 K	89 K	87 K	85 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-3.71 M	-	-2.07 M	-3.92 M	-6.43 M	-	-663 K	-605 K	-2.86 M	-	-872 K	-951 K	-1 M	-	-1.04 M	-1.9 M	-1.27 M	-	-2.32 M	-7.11 M	-11.4 M	-	-2.61 M	-4.68 M	-10.4 M	-	-2.85 M	-1.74 M	-504 K	-	-383 K	-638 K	-840 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	6.32 M	2.85 M	1.74 M	504 K	516 K	383 K	638 K	840 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	1.32 M	-	1.16 M	896 K	984 K	-	469 K	454 K	1.06 M	-	594 K	623 K	743 K	-	571 K	684 K	577 K	-	617 K	716 K	1.12 M	-	820 K	927 K	986 K	-	848 K	1.3 M	371 K	-	200 K	217 K	276 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency